Beijing Sun-Novo Pharmaceutical Research Dividends and Buybacks
Dividend criteria checks 2/6
Beijing Sun-Novo Pharmaceutical Research is a dividend paying company with a current yield of 0.39% that is well covered by earnings.
Key information
0.4%
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | 2.9% |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | CN¥0.165 |
| Payout ratio | 8% |
Recent dividend and buyback updates
No updates
Recent updates
Investors Still Aren't Entirely Convinced By Beijing Sun-Novo Pharmaceutical Research Co., Ltd.'s (SHSE:688621) Earnings Despite 40% Price Jump
Oct 02
Concerns Surrounding Beijing Sun-Novo Pharmaceutical Research's (SHSE:688621) Performance
Sep 05Market Still Lacking Some Conviction On Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHSE:688621)
Jul 31We Think Beijing Sun-Novo Pharmaceutical Research (SHSE:688621) Can Stay On Top Of Its Debt
May 29Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 688621 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 688621 has only been paying a dividend for 3 years, and since then payments have fallen.
Dividend Yield vs Market
| Beijing Sun-Novo Pharmaceutical Research Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (688621) | 0.4% |
| Market Bottom 25% (CN) | 0.5% |
| Market Top 25% (CN) | 2.1% |
| Industry Average (Life Sciences) | 1.3% |
| Analyst forecast (688621) (up to 3 years) | 2.9% |
Notable Dividend: 688621's dividend (0.39%) isn’t notable compared to the bottom 25% of dividend payers in the CN market (0.54%).
High Dividend: 688621's dividend (0.39%) is low compared to the top 25% of dividend payers in the CN market (2.12%).
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (8.4%), 688621's dividend payments are thoroughly covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (14.6%), 688621's dividend payments are thoroughly covered by cash flows.